Procurement Summary
Country : Slovakia
Summary : Antineoplastic and Immunomodulating Agents Description: Part 1 Trastuzumab Deruxtekan Plc Ifc 1x100 Mg (Inj. Glass Amber) 110 Part 2 Daratumumab Sol Inj 1x15 Ml/1800 Mg (Inj. Glass) 90 Order Type...
Deadline : 21 Feb 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 113591313
Document Ref. No. : 1541 - MST
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : EUR 505274.70
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Antineoplastic and immunomodulating agents Description: Part 1 Trastuzumab deruxtekan plc ifc 1x100 mg (inj. glass amber) 110 Part 2 Daratumumab sol inj 1x15 ml/1800 mg (inj. glass) 90 Order type: Goods 4.1.4 Scope of procurement Estimated value Estimated value (BT-27-Procedure)
Deadline for submitting bids: (date): 21/02/2025 Deadline for submitting bids (time): 09:00 Language for submitting documents Languages in which bids can be submitted: Slovak Information on bid opening Date of bid opening: 21/02/2025 Bid opening time : 10:00 Place of opening of offers: Fakultna
Documents
Tender Notice